Chronic administration of the glucagon-like peptide-1 analog, liraglutide, delays the onset of diabetes and lowers triglycerides in UCD-T2DM rats

Bethany P. Cummings, Kimber Stanhope, James L. Graham, Denis G. Baskin, Steven C. Griffen, Cecilia Nilsson, Anette Sams, Lotte B. Knudsen, Kirsten Raun, Peter J Havel

Research output: Contribution to journalArticlepeer-review

49 Scopus citations

Fingerprint Dive into the research topics of 'Chronic administration of the glucagon-like peptide-1 analog, liraglutide, delays the onset of diabetes and lowers triglycerides in UCD-T2DM rats'. Together they form a unique fingerprint.

Medicine & Life Sciences